Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Xultophy 100 units/mL + 3.6 mg/mL solution for injection

Active Ingredient:
liraglutide, insulin degludec
Company:  
Novo Nordisk Limited See contact details
ATC code: 
A10AE56
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Xultophy Educational Material

{healthcare_pro_orange} For Healthcare Professionals

Guide for Healthcare Professionals:correct use of Xultophy to minimise the risk of medication errors

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Novo Nordisk Limited
Company image
Address
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
WWW
http://www.novonordisk.co.uk
Telephone
+44 (0)1293 613555
Fax
+44 (0)1293 613535
Medical Information Direct Line
+44 (0)800 023 2573
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)800 023 2573